B

Balakrishnan

Active Director Director DIN 09315237
DIN 09315237 First appointment Sep 2021 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Balakrishnan

Data last updated:

Balakrishnan is a Director at Re-Lact Bioscience Private Limited (since 2021). The company operates in Non-Profit Organizations.

DIN 09315237
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 11 Sep 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Re-Lact Bioscience Private Limited U85300TN2021PTC146121
Director11 Sep 20212021Active

Board colleagues of Balakrishnan

NameDINCompanyDesignation
Jayakala Jothi09315238Re-Lact Bioscience Private LimitedDirector

Directorship timeline

Open interactive timeline →
Re-Lact Bioscience Private Limited
Premium access

Shareholding and investment profile for Balakrishnan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balakrishnan

Balakrishnan currently holds 1 directorship: Re-Lact Bioscience Private Limited (Director, since 11 Sep 2021).

Balakrishnan was first appointed on 11 Sep 2021 as Director at Re-Lact Bioscience Private Limited.

The current boards of Balakrishnan's companies include Jayakala Jothi (Re-Lact Bioscience Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available